81382-51-6
81382-51-6
Chemical Structure
Pentiapine
Synonym(s): CGS 10746
- CAS No.: 81382-51-6
- Formula:C15H17N5S
- Molecular Weight:299.39
IUPAC Name: 5-(4-methylpiperazin-1-yl)benzo[f]imidazo[2,1-b][1,3,5]thiadiazepine
InChIKey: FACMWMBWGSPRKO-UHFFFAOYSA-N
SMILES: CN1CCN(C2=NC3=CC=CC=C3SC4=NC=CN42)CC1
Biological Activity: Pentiapine (CGS 10746) is a dopamine release inhibitor without binding to synaptic dopamine receptor sites[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Pentiapine | 99.95% | Pentiapine (CGS 10746) is a dopamine release inhibitor without binding to synaptic dopamine receptor sites. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pentiapine (Standard) | ≥98% | Pentiapine (Standard) is the analytical standard of Pentiapine (HY-100143). This product is intended for research and analytical applications. Pentiapine (CGS 10746) is a dopamine release inhibitor without binding to synaptic dopamine receptor sites. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Manzanedo C, et al. Effects of CGS 10746B on hyperactivity and place preference induced by morphine. Behav Brain Res. 2001 Nov 29;126(1-2):23-32. [Content Brief]
- [2]. Bilsky EJ, et al. CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences. Pharmacol Biochem Behav. 1998 Jan;59(1):215-20. [Content Brief]
